UBS Group Cuts Kura Oncology (NASDAQ:KURA) Price Target to $14.00
Kura Oncology (NASDAQ:KURA – Get Free Report) had its price objective cut by equities research analysts at UBS Group from $27.00 to $14.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price objective indicates a potential upside of 85.92% from the company’s previous close. […]
Kura Oncology (NASDAQ:KURA – Get Free Report) had its price objective cut by equities research analysts at UBS Group from $27.00 to $14.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price objective indicates a potential upside of 85.92% from the company’s previous close. […]
